Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion